Not Signed In - Nastech Announces Positive Phase 1 Clinical Results Of Insulin Nasal Spray Compared To Exubera(R) Inhalation Powder And NovoLog(C) Insulin
Thu, 07 Dec 2006 08:00 AM EST
... Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) today announced results from a placebo controlled, dose-escalation, cross-over Phase 1 study of Nastech's proprietary insulin nasal spray formulations, NovoLog insulin aspart (rDNA origin) injection and Exubera (insulin human [rDNA origin]) Inhalation Powder in healthy subjects. [click link for full article] ...
Related Topics
- Insulin
- Insulin Resistance
- Insulin aspart
- Insulin Lispro
- Insulin glargine
- Clinical Trials
- Insulin - Mixed
- Glucagon
- Triamcinolone Nasal Inhalation
- Ipratropium Bromide Oral Inhalation
- Insulin glulisine
- Fluticasone Nasal Inhalation
- Beclomethasone Nasal Inhalation
- Flunisolide Nasal Inhalation
- Calcitonin Salmon Nasal Spray
- Mometasone Nasal Spray
- Sumatriptan Nasal Spray
- Zolmitriptan Nasal Spray
- Nicotine nasal spray
- Azelastine Nasal Spray
email this page
print this page
bookmark this page
feedback on this page
